Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A.
暂无分享,去创建一个
M. Viitasalo | L. Toivonen | K. Kontula | H. Swan | K. Piippo | M. Raatikka | S. Holmström
[1] D M Roden,et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] A J Moss,et al. Spectrum of Mutations in Long-QT Syndrome Genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 , 2000, Circulation.
[3] J. Kaprio,et al. Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects , 2000, Human mutation.
[4] S. Priori,et al. Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias , 2000, Journal of cardiovascular electrophysiology.
[5] A. Sajantila,et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. , 2000, Journal of the American College of Cardiology.
[6] R. Woosley,et al. Mechanism of cardiotoxicity of halofantrine , 2000, Clinical pharmacology and therapeutics.
[7] A. Wilde,et al. Cardiac conduction defects associate with mutations in SCN5A , 1999, Nature Genetics.
[8] S. Waxman,et al. Activation and Inactivation of the Voltage-Gated Sodium Channel: Role of Segment S5 Revealed by a Novel Hyperkalaemic Periodic Paralysis Mutation , 1999, The Journal of Neuroscience.
[9] M. Keating,et al. MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.
[10] G. Breithardt,et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.
[11] P. Coumel,et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. , 1997, Circulation.
[12] Z. Li,et al. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. , 1996, Genomics.
[13] Arthur J Moss,et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.
[14] J. Karbwang,et al. Clinical Pharmacokinetics of Halofantrine , 1994, Clinical pharmacokinetics.
[15] M. Viitasalo,et al. Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome , 1994, Clinical cardiology.
[16] M. Viitasalo,et al. Molecular genetics of the long QT syndrome: Two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred , 1998, Human mutation.
[17] Vincent Gm,et al. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. , 1998 .